Most of the Colombian insurance sector is reading Decree 0173 wrong. The dominant interpretation frames it as over-regulation. The interpretation that makes economic sense frames it as a selection mechanism.
The public backing from Fasecolda and the newly constituted Insurtech Association of Colombia does not mean the decree is unfair. It means the sector recognizes that compliance cost will be unequal: top 5 insurers already have the systems and the teams to absorb it. Mid-market insurers between rank 15 and 30 do not. That asymmetry is exactly what the decree will institutionalize.
The reading your competition is probably getting wrong
Three common ways of reading Decree 0173 that lead to the wrong decision. First, reading it as an accounting compliance problem. It is not. The granularity in reserves, prudential reporting and operational traceability requires reconfiguring systems, not just processes. Second, assuming AIC and Fasecolda will push to postpone it. Historically Colombia has made technical adjustments to this kind of decree, but rarely has it rescinded the regulatory principle. Third, waiting to see how the top 5 implement it before acting. By then the catch-up cost is 2x.
The reading top 5 insurers already made
Tier-1 Colombian insurers did not respond to the decree expecting postponement. They responded by accelerating investment on four simultaneous fronts: core systems reconfigured to support hardened IFRS 17 granularity, claims automation with computer vision to reduce loss adjustment expenses, systemic fraud detection applied to the portfolio, and reinsurance automation to handle the front at speed. They did so because they understood the decree is not an accounting tweak. It is a hardening of the conditions under which share will be competed for.
If your insurer is modeling Decree 0173 as compliance cost, the internal conversation is framed wrong. It is investment under a new competitive regime. Confusing the two costs margin points.
Three common objections and why they fail
Objection one: the sector will pressure for softer scope. AIC and Fasecolda will likely achieve specific technical wins. The regulatory principle (more granularity, more traceability, higher reporting frequency) will not be reversed. Betting otherwise bets against the Superfinanciera's track record over the last five years.
Objection two: it is adjustment, not transformation. The granularity the decree requires breaks the legacy stacks typical of mid-market insurers. AS/400, old Oracle EBS, and heterogeneous integrations do not natively support it. Treating the transformation as optional underestimates the technical magnitude.
Objection three: we can wait to see implementation. The cost of waiting is high in two vectors. First, catch-up cost when every software provider is saturated. Second, competitive cost: insurers that close hardened IFRS 17 plus claims automation plus fraud detection earlier capture share before the next pricing round.
What the mid-market insurer that sees the play actually does
Three concrete moves. First, commission an independent operational diagnostic that maps the gap between the current stack and what the decree demands. The diagnostic does not rely solely on the internal team because status quo bias is predictable. Second, prioritize claims automation over reinsurance automation because the former captures USD 200 to 500K per year in undetected fraud while accounting transformation advances. Third, structure the investment in 12 to 15 months to avoid a lost decade of catch-up.
The question LIFE·IN·CO can help you answer
Decree 0173 forced the sector into a conversation that had been postponed. Top 5 insurers are in execution. Mid-market insurers entering serious planning now have until 2027 to avoid falling behind. The operating question for your board is not whether the decree is fair. It is whether the next six months are enough to move four fronts in parallel.